6VOD

HIV-1 wild type protease with GRL-052-16A, a tricyclic cyclohexane fused tetrahydrofuranofuran (CHf-THF) derivative as the P2 ligand

Summary for 6VOD

Entry DOI	10.2210/pdb6vod/pdb
Related	2IEN 5ULT 6BZ2 6CDJ 6CDL 6VOE
Descriptor	Protease, SODIUM ION, CHLORIDE ION, ... (7 entities in total)
Functional Keywords	inhibitors, antiviral, multidrug-resistant, chf-thf, backbone binding, antiviral protein
Biological source	Human immunodeficiency virus 1
Total number of polymer chains	2
Total formula weight	22302.08
Authors	Wang, Y.-F.,Agniswamy, J.,Weber, I.T. (deposition date: 2020-01-30, release date: 2020-05-13, Last modification date: 2023-10-11)
Primary citation	Ghosh, A.K.,Kovela, S.,Osswald, H.L.,Amano, M.,Aoki, M.,Agniswamy, J.,Wang, Y.F.,Weber, I.T.,Mitsuya, H. Structure-Based Design of Highly Potent HIV-1 Protease Inhibitors Containing New Tricyclic Ring P2-Ligands: Design, Synthesis, Biological, and X-ray Structural Studies. J.Med.Chem., 63:4867-4879, 2020 Cited by PubMed: 32348139 DOI: 10.1021/acs.jmedchem.0c00202 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.25 Å)

Structure validation